Nektar Therapeutics (NKTR)
$23.04 0.17 (0.74%)
17:45 EDT NKTR Stock Quote Delayed 30 Minutes
Previous Close $23.04
Market Cap 3.95B
PE Ratio -28.80
Volume (Avg. Vol.) 839,100
Day's Range 22.84 - 23.07
52-Week Range 13.63 - 36.85
Dividend & Yield N/A (N/A)
NKTR Stock Predictions, Articles, and Nektar Therapeutics News
- From InvestorPlace
- From the Web
The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
Wells Fargo, HP and Gilead Sciences are just three oversold stocks to sell before they lose any more ground.
Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.
As we move into the weekend, the stock charts of AOS, NKTR and WAT should be on your radar.
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd.
Sellers dominated the trading action on Nektar stock after its preliminary clinical results. Over-reaction or justified selling? The market simply did not understand the results, hurting the NKTR stock price.
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors.
Nektar Therapeutics pulled back in recent weeks, and that is a good thing. Valuations are stretched, but the upside in NKTR stock is high if management delivers.
3 Stocks to Watch on Friday: Alphabet Inc (GOOG, GOOGL), Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG)
Alphabet Inc (GOOG,GOOGL) is fixing latency issues with Google Home Max, while Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG) reported earnings.
It may be all about taxes now, but 2018 is all about healthcare. The following are some of the best healthcare stocks to buy in 2018.
In the end, the Dow lost a fraction, the S&P gave back 0.2%, the Nasdaq gained a fraction and the Russell 2000 finished the day 0.5% lower.
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
From Seeking Alpha
From Simply Wall St
Today we will run through one way of estimating the intrinsic value of Consolidated Edison, Inc. (NYSE:ED) by taking the expected future cash flows and discounting them to their present<div><a class="permalink" href="https://simplywall.st/stocks/us/utilities/nyse-ed/consolidated-edison/news/calculating-the-intrinsic-value-of-consolidated-edison-inc-nyseed/">Read More...</a></div>
From Analyst Ratings
In a report released today, Michael Weinstein W. from Credit Suisse maintained a Sell rating on Consolidated Edison (ED – Research Report), with a price target of $76.00. The company’s shares closed last Friday at $73.27. According to TipRanks.com, W. is a 4-star analyst with an average return of 4.5% and a 57.1% success rate.
Navellier RatingsPowered by Portfolio Grader